PACB News and Press, Pacific Biosciences of California Inc. From 09/27/22

PacBio Unveils a New Method for Comprehensive, Genome-wide Tandem Repeat Analysis PR Newswire Analysis Method Supports Research on the Genetic Causes of Common Diseases MENLO PARK, Calif. , Sept. 27, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB),...

PacBio to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference PR Newswire MENLO PARK, Calif. , Sept. 7, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced...

Recent volatility mirror renewed meme-trade bonanza, likely to subdue in coming days, instead of a reflection of a change in the company's market position. Several factors distorted the YoY revenue comparison this quarter, contributing to the inflated top-line growth, including the Bi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: motorolka / Shutterstock.com Various biotech stocks are in focus today, but Pacific Biosciences  (NASDAQ: PACB ) is one of the more notable names investors are watching right now. At the time of this w...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cathie Wood’s exchange-traded funds (ETFs) received a breath of fresh air this week. The ARK Innovation ETF (NYSEMKT: ARKK ) ended the period up over 12%. Wood did admit that she believes the U.S. is current...

PacBio to Participate in the UBS Genomics 2.0 and MedTech Innovations Summit PR Newswire MENLO PARK, Calif. , Aug. 5, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will be participating in the upcoming UBS Genomics 2.0 and MedTech Inn...

Image source: The Motley Fool. Pacific Biosciences of California (NASDAQ: PACB) Q2 2022 Earnings Call Aug 03, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Pacific Biosciences of California (PACB) Q2 2022 Earnings...

Pacific Biosciences of California, Inc. (PACB) Q2 2022 Earnings Conference Call August 03, 2022 5:00 PM ET Company Participants Todd Friedman – Director of Investor Relations Christian Henry – President and Chief Executive Officer Susan Kim –...

Pacific Biosciences of California press release ( NASDAQ: PACB ): Q2 Non-GAAP EPS of -$0.34 in-line. Revenue of $35.5M (+16.0% Y/Y) beats by $0.34M . For further details see: Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M ...

PacBio Announces Second Quarter 2022 Financial Results PR Newswire MENLO PARK, Calif. , Aug. 3, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2022 . Second quarter results...